The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Varshavskiĭ V.A.

Kafedra patologicheskoĭ anatomii im. A.I. Strukova GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova" Minzdrava Rossii

Grishina A.N.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Chebotareva N.V.

Medical University «Russian University of Friendship of Peoples» Ministry of Health of the Russian Federation, Moscow, Russia, 117198

Gudkova E.I.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

The clinical and morphological characteristics of C1q glomerulopathy

Authors:

Varshavskiĭ V.A., Grishina A.N., Chebotareva N.V., Gudkova E.I.

More about the authors

Read: 2096 times


To cite this article:

Varshavskiĭ VA, Grishina AN, Chebotareva NV, Gudkova EI. The clinical and morphological characteristics of C1q glomerulopathy. Russian Journal of Archive of Pathology. 2018;80(1):46‑51. (In Russ.)
https://doi.org/10.17116/patol201880146-51

References:

  1. Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis. 1985;6(2):103-110. https://doi.org/10.1016/s0272-6386(85)80150-5
  2. Vizjak A, Ferluga D, Rozic M, Hvala A, Lindic J, Levart TK, Jurcić V, Jennette JC. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol. 2008;19(11):2237-2244. https://doi.org/10.1681/asn.2007080929
  3. Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D’Agati VD. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int. 2003;64(4):1232-1240. https://doi.org/10.1046/j.1523-1755.2003.00218.x
  4. Iskandar SS, Browning MC, Lorentz WB. C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis. 1991;18(4):459-65. https://doi.org/10.1016/s0272-6386(12)80114-4
  5. Lim IS, Yun KW, Moon KC, Cheong HI. Proteinuria in a boy with infectious mononucleosis, C1q nephropathy, and Dent’s disease. J Korean Med Sci. 2007;22(5):928-31. https://doi.org/10.3346/jkms.2007.22.5.928
  6. Isaac J, Shihab FS. De novo C1q nephropathy in the renal allograft of a kidney pancreas transplant recipient: BK virus-induced nephropathy. Nephron. 2002;92(2):431-436. https://doi.org/10.1159/000063313
  7. Walport MJ. Complement: first of two parts. N Engl J Med. 2001;344(14):1058-1066. https://doi.org/10.1016/b978-012733360-1/50003-8
  8. Thomas DB. Focal segmental glomerulosclerosis: a morphologic diagnosis in evolution. Arch Pathol Lab Med. 2009;133(2):217-223. https://doi.org/10.1111/j.1440-1797.2006.00641.x
  9. Hisano S, Matsushita M, Fujita T. Activation of the lectin complement pathway in C1q nephropathy. Clin J Am Soc Nephrol. 2007;57(6):351-357. https://doi.org/10.1111/j.1440-1827.2007.02107.x
  10. Malleshappa P. C1q nephropathy — unity in diversity. J Renal Injury Prev. 2013;2(4):117-118. https://doi.org/10.5812/numonthly.8308
  11. Sinha A, Nast CC, Hristea I, Vo AA, Jordan SC. Resolution of clinical and pathologic features of C1q nephropathy after rituximab therapy. Clin Exp Nephrol. 2011;15(1):164-170. https://doi.org/10.1007/s10157-010-0377-x
  12. Bitzan M, Ouahed JD, Krishnamoorthy P, Bernard C. Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution. Pediatr Nephrol. 2008;23(8):1355-1361. https://doi.org/10.1007/s00467-008-0781-6

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.